HOPCo Expands its Musculoskeletal Population Health Program with Humana Partnership and its Arizona Members
HOPCo and Humana (NYSE: HUM) announced a partnership effective Oct. 28, 2025 to add eligible Humana members in Arizona to HOPCo's musculoskeletal (MSK) population health platform.
HOPCo will deploy its Integrated Care System (ICS), digital engagement tools including myrecovery, and its statewide HOPCo Specialty Care Network (HSCN) to connect members, primary care providers, and more than 230 MSK specialty physicians in Arizona under evidence-based protocols. HSCN is described as the only URAC-accredited MSK CIN in the U.S. The release also notes HOPCo's recent acquisition of AI-powered digital health company Caro Health.
HOPCo e Humana (NYSE: HUM) hanno annunciato una partnership efficace dal 28 ottobre 2025 per aggiungere agli utenti Humana eleggibili in Arizona alla popolazione di salute muscolo-scheletrica (MSK) della piattaforma di population health di HOPCo.
HOPCo implementerà il proprio Integrated Care System (ICS), strumenti di coinvolgimento digitale tra cui myrecovery e la sua Rete di Cura Specialistica HOPCo (HSCN) a livello statale per connettere membri, fornitori di cure primarie e oltre 230 medici specialisti MSK in Arizona, secondo protocolli basati sull’evidenza. HSCN è descritta come l’unico URAC-accredited MSK CIN negli Stati Uniti. Il comunicato menziona anche l’acquisizione recente da parte di HOPCo della società di salute digitale alimentata dall’IA Caro Health.
HOPCo y Humana (NYSE: HUM) anunciaron una asociación vigente desde el 28 de octu bre de 2025 para agregar a los miembros elegibles de Humana en Arizona a la población de salud musculoesquelética (MSK) de la plataforma de salud poblacional de HOPCo.
HOPCo desplegará su Integrated Care System (ICS), herramientas de participación digital incluyendo myrecovery, y su Red de Cuidado Especializado HOPCo (HSCN) a nivel estatal para conectar a miembros, proveedores de atención primaria y a más de 230 médicos especialistas en MSK en Arizona bajo protocolos basados en la evidencia. Se describe que HSCN es el único URAC-accredited MSK CIN en EE. UU. El comunicado también señala la reciente adquisición de la empresa de salud digital impulsada por IA Caro Health.
HOPCo와 Humana (NYSE: HUM)은 2025년 10월 28일부로 효력이 발생하는 파트너십을 발표했고, 애리조나주(Arizona)의 Humana 유자격 구성원을 HOPCo의 근골격계(MSK) 인구 건강 관리 플랫폼에 추가합니다.
HOPCo는 통합 케어 시스템(ICS), myrecovery를 포함한 디지털 참여 도구, 주 전역의 HOPCo 전문 진료 네트워크(HSCN)을 배포하여 구성원, 1차 진료 제공자, 그리고 애리조나 주의 230명 이상 MSK 전문의와 연결하고, 증거 기반 프로토콜에 따라 운영합니다. HSCN은 미국에서 유일한 URAC 인증 MSK CIN으로 설명됩니다. 또한 발표에는 AI 기반 디지털 헬스 기업 Caro Health의 최근 인수도 언급됩니다.
HOPCo et Humana (NYSE: HUM) ont annoncé un partenariat en vigueur à partir du 28 octobre 2025 pour ajouter les membres éligibles de Humana en Arizona à la population de santé musculo-squelettique (MSK) de la plateforme de santé populationnelle de HOPCo.
HOPCo déploiera son Integrated Care System (ICS), des outils d’engagement numérique dont myrecovery, et son réseau de soins spécialisés HOPCo (HSCN) à l’échelle de l’État pour connecter les membres, les fournisseurs de soins primaires et plus de 230 médecins spécialistes MSK en Arizona selon des protocoles basés sur des preuves. Le HSCN est décrit comme le seul MSK CIN accrédité URAC aux États‑Unis. Le communiqué mentionne également l’acquisition récente par HOPCo de la société de santé numérique alimentée par l’IA Caro Health.
HOPCo und Humana (NYSE: HUM) gaben eine Partnerschaft bekannt, die ab dem 28. Oktober 2025 wirksam ist, um eligiblen Humana-Mitgliedern in Arizona zur MSK-Populationsgesundheitsplattform von HOPCo hinzuzufügen.
HOPCo wird sein Integrated Care System (ICS), digitale Engagement-Tools einschließlich myrecovery und sein landesweites HOPCo Specialty Care Network (HSCN) implementieren, um Mitglieder, Primärversorger und mehr als 230 MSK-Spezialärzte in Arizona gemäß evidenzbasierter Protokolle zu vernetzen. HSCN wird als das einzige URAC-akkreditierte MSK CIN in den USA beschrieben. Die Mitteilung erwähnt auch die jüngste Übernahme des KI-gestützten digitalen Gesundheitsunternehmens Caro Health.
HOPCo و Humana (NYSE: HUM) يعلنان عن شراكة سارية اعتباراً من 28 أكتوبر 2025 لإضافة أعضاء Humana المؤهلين في أريزونا إلى منصة الصحة السكانية للعضلات والمفاصل (MSK) التابعة لـ HOPCo.
ستنفذ HOPCo نظام الرعاية المتكامل (ICS)، وأدوات المشاركة الرقمية بما في ذلك myrecovery، وشبكة الرعاية التخصصية HOPCo (HSCN) على مستوى الولاية لربط الأعضاء ومقدمي الرعاية الأولية وأكثر من 230 طبيباً اختصاصياً في MSK في أريزونا وفق بروتوكولات قائمة على الأدلة. وتُوصف HSCN بأنها الحصري الوحيد URAC-accredited MSK CIN في الولايات المتحدة. كما يذكر البيان الاستحواذ الأخير لشركة Caro Health، شركة صحة رقمية مدعومة بالذكاء الاصطناعي.
HOPCo 与 Humana (NYSE: HUM) 宣布自2025年10月28日起生效的合作伙伴关系，以将
HOPCo 将部署其集成护理系统（ICS）、包括 myrecovery 在内的数字参与工具，以及其全州范围的 HOPCo 专科护理网络（HSCN），以在亚利桑那州将成员、初级保健提供者以及超过 230 名 MSK 专科医生 连接起来，遵循循证协议。HSCN 被描述为美国唯一的 URAC 认证的 MSK CIN。新闻稿还提到 HOPCo 最近收购了由人工智能驱动的数字健康公司 Caro Health。
- Partnership adds Humana Arizona members to HOPCo MSK platform (Oct 28, 2025)
- HSCN aligned 230+ MSK specialty physicians across Arizona
- URAC-accredited status: only MSK CIN with URAC accreditation in the U.S.
- Integrated Care System plus myrecovery digital tools and omnichannel care
- None.
Insights
HOPCo expands its MSK value‑based platform to eligible Humana members in Arizona, scaling provider alignment and digital engagement.
HOPCo’s platform combines a statewide clinically integrated network with digital engagement tools and medical economics to standardize MSK care delivery for Humana members in Arizona. The integration emphasizes upstream PCP engagement, omnichannel care (in‑person, virtual, hybrid), and real‑time claims analytics through the HOPCo Specialty Care Network and the myrecovery® tools.
Key dependencies and risks include actual member uptake, PCP and specialist referral behavior, and the ability to translate protocols into measurable cost and quality improvements within Humana’s Arizona population. The announcement notes the recent acquisition of Caro Health, which may extend digital capabilities but requires operational integration.
Watch for concrete performance signals over the next 6–18 months such as enrollment figures, adherence to evidence‑based protocols across the HSCN, measurable quality metrics, and published cost or utilization outcomes; the press release date is
HOPCo's unique specialty care platform, empowered with integrated analytics and member engaging digital tools, will align providers and members around clinical best practices and is now available for eligible Humana members receiving musculoskeletal (MSK) care across
HOPCo's proprietary platform, which includes integrated provider and patient digital engagement solutions, a comprehensive evidence-based care delivery infrastructure, and proven value-based care medical economics platform, is being deployed to a growing population of payors and members. HOPCo will use its digitally powered Integrated Care System (ICS) ensuring members with MSK conditions rapidly receive the correct therapies and care management with the most appropriate provider and in the most appropriate setting, all while being guided and monitored by MSK clinical experts adhering to evidence-based protocols through a unique combination of omnichannel in-person, virtual, and hybrid interactions.
Unlike point solutions that often focus on a limited portion of the patient journey, HOPCo's value-based care platform engages members and providers across the entire MSK care continuum at all points of care. The platform utilizes proprietary digital engagement tools including
myrecovery
®
, to engage members fully upstream with primary care providers (PCPs) as well as with MSK specialists through HOPCo's statewide
clinically integrated network (CIN
), the
HOPCo Specialty Care Network (HSCN)
. HSCN, the only URAC-accredited MSK CIN in the country, has aligned more than 230 MSK specialty physicians across
"We continue to see great enthusiasm from payors and risk-bearing entities for HOPCo's proven solutions that engage members and all stakeholders aligning care around evidence-based best practices across all points of the patient journey," said Jason Scalise, MD, Chief Value Officer at HOPCo. "Our dedicated upstream PCP engagement platform combined with our statewide MSK specialty CIN, fully integrated digital engagement tools and sophisticated medical economics and analytics is far more effective than isolated point solutions. It is instead, a solution for every point of care." Additional payors and risk bearing entities in
About Healthcare Outcomes Performance Company (HOPCo)
Healthcare Outcomes Performance Company (HOPCo) is the global leader in musculoskeletal (MSK) value-based care, outcomes management, and care transformation. HOPCo partners with physician practices, health systems, payors, and suppliers to implement clinically integrated models that improve quality, reduce variability, and lower the total cost of MSK care.
Through HOPCo Digital, its advanced technology and AI platform, HOPCo is building the most comprehensive solution for practices, ambulatory surgery centers, payors, suppliers, and health systems enabling integrated, data-driven, and patient-centered care. HOPCo's global footprint includes partnerships worldwide, with teams on the ground supporting successful implementations in both emerging and mature healthcare systems and markets.
Visit
www.hopco.com
to learn more.
Follow us on LinkedIn, Instagram and Facebook
View original content to download multimedia:https://www.prnewswire.com/news-releases/hopco-expands-its-musculoskeletal-population-health-program-with-humana-partnership-and-its-arizona-members-302596790.html
SOURCE Healthcare Outcomes Performance Company
FAQ
What did HOPCo and Humana (HUM) announce on October 28, 2025 regarding Arizona members?
How many MSK specialty physicians are aligned with HOPCo's HSCN in Arizona?
What digital tools will HOPCo use for Humana (HUM) members in Arizona?
Does the HOPCo–Humana partnership cite any clinical accreditation for the network?
Did HOPCo mention any recent acquisitions alongside the Humana (HUM) partnership?
What is the stated goal of HOPCo's MSK program for Humana (HUM) members in Arizona?
